A Metabolism-Driven Prognostic Model and PSMD14-SP1-GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma. Xie J, Zhao S, Wu D, Ma C, et al. J Invest Dermatol 2025 Sep 16:S0022-202X(25)02430.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie J, Zhao S, Wu D, Ma C, et al. A Metabolism-Driven Prognostic Model and PSMD14-SP1-GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma. J Invest Dermatol 2025 Sep 16:S0022-202X(25)02430.
PMID: 40967300